Uncovers hub genes driving liver cancer phenotypes, suggesting new targets for treatment.
Objective: Hepatocellular carcinoma (HCC) is a molecularly heterogeneous malignancy with high mortality. This study aimed to identify differentially expressed genes (DEGs) between tumor and non-tumor liver tissue and, through protein–protein interaction (PPI) network analysis, to reveal hub genes central to HCC pathogenesis. Materials and Methods: Using the GSE76427 dataset from the Gene Expression Omnibus, 115 HCC tumor tissues were compared with 52 non-tumor liver tissues. Differential expression analysis was performed with the limma package (adj. P. Val < 0.05, |logFC| ≥ 1). The most strongly dysregulated genes were submitted to the STRING database to construct a PPI network, and the network topology was evaluated. Results: A total of 362 probes were differentially expressed (95 up-regulated, 267 down-regulated). The roughly three-fold excess of down-regulated genes reflects loss of liver-specific metabolic and detoxification programs. PPI analysis revealed a network significantly richer in interactions than expected (enrichment p = 4.67 × 10⁻⁵); the cell-cycle– and mitosis-related proteins PCLAF, PRC1, MCM2, UBE2T and TUBA1C formed a tightly connected proliferation module that constituted the network core, whereas down-regulated genes associated with sinusoidal endothelium, innate immunity and hepatocyte metabolism appeared largely as isolated nodes. Conclusion: The findings indicate that the HCC phenotype is driven mainly by a proliferation-centered interaction network accompanied by loss of liver-specific differentiation. The hub proteins within this proliferation module stand out as candidate biomarkers and therapeutic targets for HCC.
No takes yet. Share an insight, caveat, or question.
Ipek Balikci Cicek 1 Zeynep Kucukakcali1* (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: